Eckburg Paul 4
4 · AN2 Therapeutics, Inc. · Filed May 16, 2022
Insider Transaction Report
Form 4
Eckburg Paul
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-05-12+66,000→ 66,000 totalExercise: $17.28Exp: 2032-05-11→ Common Stock (66,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary as measured from March 25, 2022.